ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Patent Law

: Patent Docs

Biotech/Pharma Docket

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

ADVERTISEMENTS
By James DeGiulio -- Eisai's Motion to Dismiss Granted in Aricept Suit with Apotex Apotex's Abbreviated New Drug Application (ANDA) to market a generic version of Aricept remains unapproved following the dismissal of the generic drug company's declaratory judgment suit seeking invalidity or noninfringement of Eisai's patent on the drug. In 2003, Ranbaxy was the first to file an ANDA for generic Aricept, also asserting that U.S. Patent Nos. 5,985,864, 6,140,321, 6,245,911, and 6,372,760 were either invalid or would not be infringed by its generic version of the drug. However, Ranbaxy did not challenge the U.S. Patent No. 4,895,841, which...

Full post as published by Patent Docs on September 10, 2010 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0142 secs (new cache)